As of Jul 02
| +1.28 / +1.30%|
The 29 analysts offering 12-month price forecasts for Novartis have a median target of 115.42, with a high estimate of 125.27 and a low estimate of 94.22. The median estimate represents a +15.65% increase from the last price of 99.80.
The current consensus among 33 polled investment analysts is to Buy stock in Novartis. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.